Phase 1Completed
A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg (DWCZP-I-1)
Clinical Trials to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg After a Multi-dose Oral Administration in Schizophrenia Patients
- Sponsor
- Dong Wha Pharmaceutical Co. Ltd. (Industry)
- Enrollment
- 28 enrolled
- Conditions
- Schizophrenia
- Interventions
- DWCZP; Clozaril
- Ages
- adults
- Registry
- NCT01654601
Full record on ClinicalTrials.gov
From the registry
To evaluate the pharmacokinetics of oral multiple-dose of DWCZP tablet 100mg.
Primary outcomes
- Maximum Concentration of Clozapine in Plasma
History
Last registry update
Results first posted
Study completion
Primary completion
Registered
Started